LB Pharmaceuticals, Inc.
Pioneering advancements in CNS treatment by bringing overseas innovations to the U.S. market through dedicated research and improved drug versions.
General Information
BounceWatch is an independent company data service, not affiliated with LB Pharmaceuticals, Inc.. To contact LB Pharmaceuticals, Inc., visit lbpharma.us.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does LB Pharmaceuticals, Inc. compare?
A PDF of LB Pharmaceuticals, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting LB Pharmaceuticals, Inc. soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.
Heather Turner, CEO of LB Pharmaceuticals, Inc., recently participated as a guest on the Fuel For Female Founders podcast.
About LB Pharmaceuticals, Inc.
Business keywords: CNS treatment, life sciences, innovation, drug development, research-driven, intellectual property, commercialization, overseas innovations, drug versions, development stage, commercializing, US market, research-focused, pharmaceuticals, medication marketing
Funding Rounds & Investors (11)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Private Placement VC | $100.00M | 9 |
|
01 Feb 2026 |
| IPO | $285.00M | - |
|
01 Sep 2025 |
| Series C | $75.00M | - |
|
01 Jan 2024 |
| Convertible Note | $35.00M | - |
|
01 Sep 2023 |
| Late VC | $16.57M | 1 |
|
01 Nov 2022 |
| Convertible Note | $10.00M | - |
|
01 Sep 2020 |
| Series A | $8.40M | 1 |
Rivopharm
|
01 Mar 2019 |
| Early VC | $6.30M | - |
|
01 Nov 2018 |
| Early VC | $440.00K | - |
|
01 Dec 2017 |
| Seed | $460.00K | - |
|
01 Apr 2017 |
LB Pharmaceuticals, Inc. Alternatives & Competitors
View All Alternatives
developing innovative drugs and drug delivery systems that improve the quality of life of oncology p...
Hua Medicine is a leading clinical-stage, innovative drug development company in China, focusing on...
MOTIVATED TO MAKE BETTER DRUGS - POWERED WITH TUMOR DATA - DELIVERED BY MACHINE LEARNING
FAQ About LB Pharmaceuticals, Inc.
Source: BounceWatch company record for LB Pharmaceuticals, Inc., https://bouncewatch.com/company/lb-pharmaceuticals-inc, updated 10 June 2026. When citing, please name BounceWatch and link this page.
